Despite the recently reported national decline in opioid overdose deaths, many U.S. communities, including New Orleans, continue to see an ...

The approval is based on a multi-center, randomized, double-blind, placebo-controlled phase III study to confirm the efficacy and safety of Stapokibart injection in treatment of adult patients with ...

Keymed Biosciences (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") of China has recently approved the supplemental ...

The money will pay for efforts to prevent and treat opioid addiction, or fund services that help people in recovery.

Nasal irrigation can be a useful addition to the management of chronic upper respiratory conditions, including nasal ...

The Oshkosh Area School District announced the expansion of its emergency preparedness resources, with the installation of ...

Most people rely on medicines daily to manage long-term health conditions, treat immediate medical needs, and maintain their ...

THREE of the most dangerous medicines in the world have been revealed – and millions of Brits already use them. A cold and ...

Investing.com -- AIM ImmunoTech (NYSE: AIM) Inc. (NYSE American: AIM) has announced its intention to develop Ampligen as a vaccine adjuvant for avian influenza. This move is part of AIM's antiviral ...

Each of the RSU grants vests ratably in equal installments on the first, second, and third anniversaries of the grant date, subject to the recipient's continued service with the Company through the ...

The most recent trends show that RSV levels rose and peaked in December and have started to decrease since January. Justman ...

Company had $98.8 million in cash as of December 31, 2024; existing cash expected to fund planned operations into the first quarter of 2026 Company is debt-free after repaying mortgage on facilities ...